Description

6-Bromo-7-Methoxy-Quinazolin-2-Ylamine is a high-purity, advanced pharmaceutical intermediate with a defined molecular structure. This compound matters as a critical building block in the synthesis of targeted kinase inhibitors, enabling the development of novel therapeutic agents. It is primarily needed by research institutions and pharmaceutical manufacturers engaged in oncology and anti-inflammatory drug discovery programs. Our supply ensures consistent quality and reliable availability for your complex synthesis workflows.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of quinazoline-based kinase inhibitors for targeted cancer therapies.
• Drug Discovery Research: Used in medicinal chemistry for structure-activity relationship (SAR) studies and lead optimization.
• Chemical Synthesis: Serves as a versatile building block for constructing complex heterocyclic compounds in organic chemistry.
• Biochemical Research: Employed in the development of biochemical probes and assay tools for studying enzyme activity.
• Reference Standard: Utilized as a high-purity analytical standard for quality control and method validation in API manufacturing.

Basic Information

Product Name	6-Bromo-7-Methoxy-Quinazolin-2-Ylamine
CAS No.	914397-12-9
Molecular Formula	C9H8BrN3O
Molecular Weight	254.08 g/mol
Synonyms	2-Amino-6-bromo-7-methoxyquinazoline; 6-Bromo-7-methoxy-2-quinazolinamine; 7-Methoxy-6-bromoquinazolin-2-amine; 914397-12-9; Quinazolin-2-amine, 6-bromo-7-methoxy-; 6-Bromo-7-methoxyquinazolin-2-ylamine; 2-Quinazolinamine, 6-bromo-7-methoxy-
EINECS	Contact for details

Quality Control

Our 6-Bromo-7-Methoxy-Quinazolin-2-Ylamine is manufactured under strict quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. We provide a detailed Certificate of Analysis (COA) with each shipment, documenting all critical specifications. Our quality commitment supports compliance with cGMP guidelines for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). The product is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.